trending Market Intelligence /marketintelligence/en/news-insights/trending/87L0GJpxWg4YipNmfH_5hQ2 content esgSubNav
In This List

Cellular Biomedicine board approves $10M stock repurchase program

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Cellular Biomedicine board approves $10M stock repurchase program

The Cellular Biomedicine Group Inc. board approved a $10 million stock repurchase program.

The stocks will be repurchased through the open market.